Media

The Biotechnology Innovation Organization (BIO) is pleased to announce that the Honorable Dennis McGinn, Assistant Secretary of the Navy, Energy, Installations...
BIO Executive Vice President for Health Policy Dan Durham released the following statement regarding yesterday’s proposed Part B Drug Payment Model and...

Press Releases

Jan 21 2016
Washington, D.C. (January 20, 2016) – The Biotechnology Innovation Organization (BIO) applauds the release yesterday by Senate Health Committee Chairman...
Jan 14 2016
Washington, D.C. (January 14, 2016) – The Biotechnology Innovation Organization (BIO) announced today that registration is now open for the 2016 BIO...
Jan 12 2016
Washington, D.C. (January 12, 2016) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood released the following statement today...
Jan 12 2016
Washington, D.C. (January 12, 2016) – The Biotechnology Innovation Organization (BIO) is pleased to announce the winners of the 2016 BIO CEO &...
Jan 7 2016
Washington, D.C. (January 7, 2016) – The Biotechnology Innovation Organization (BIO) announced today that long-time healthcare policy expert Dan Durham...
Jan 4 2016
Washington, D.C. (January 4, 2016) – To better reflect the remarkable progress and groundbreaking innovations its members achieve in healing, fueling and...
Dec 16 2015
The Biotechnology Industry Organization (BIO) today welcomed legislation to extend critical tax incentives that are important to biotechnology companies. The...
Dec 8 2015
Washington, D.C. (December 9, 2015) – Today, the Biotechnology Industry Organization (BIO) and Parent Project Muscular Dystrophy (PPMD) announce the...
Dec 2 2015
Washington, D.C. (December 2, 2015) – Brian Hahn, Chief Financial Officer of GlycoMimetics, Inc., provided testimony today on behalf of the Biotechnology...


Biotechnology News

Mar 2 2016 - 1:36am
KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Biopharmaceuticals, Inc. (NYSE MKT: PVCT, www.pvct.com), a clinical-stage oncology and dermatology biopharmaceutical company ("Provectus" or “The Company”), today announced that it has received a patent from the U.S. Patent and Trademark Office, U.S. Patent No. 9,273,022. The patent extends the scope of protection of the manufacturing process conferred initially by U.S. Patent No. 8,530,675, issued in 2013, to include coverage of the use of an altern

Mar 2 2016 - 1:36am
LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (NASDAQ:AGEN), an immuno-oncology company developing checkpoint modulator antibodies and cancer vaccines, today announced that Garo Armen, Ph.D., Chairman and CEO, and Robert B. Stein, M.D., Ph.D., President, R&D at Agenus will present at the Cowen and Company 36th Annual Health Care Conference on Monday, March 7th at 4:40pm ET. The conference will take place at The Boston Marriott Copley Place in Boston, MA. Webcast Information The live and ar

Mar 2 2016 - 1:36am
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Pronutria Biosciences to Present at the Cowen and Company 36th Annual Health Care Conference

Mar 2 2016 - 1:36am
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic candidates that regulate cellular growth and repair, today announced that senior management will participate in four upcoming healthcare investor conferences in March. Conference Details: Event:   Cowen and Company 36th Annual Health Care Conference Date / Time: Wednesday, March 9, 2016 at 10:40 AM EST

Mar 2 2016 - 1:36am
HIGH POINT, N.C.--(BUSINESS WIRE)--vTv Therapeutics Inc. (Nasdaq:VTVT), a clinical-stage biopharmaceutical company engaged in the discovery and development of new orally administered treatments for Alzheimer’s disease and diabetes, today reported business highlights and financial results for the fourth quarter and year ended December 31, 2015. In addition, vTv provided an update on recent developments and upcoming milestones for its lead clinical development programs. “Over the past year, we ha

Mar 2 2016 - 1:36am
BOSTON--(BUSINESS WIRE)--Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer, today announced that the Company will host a conference call and webcast on Thursday, March 3, 2016 at 8:30 a.m. Eastern Time to discuss corporate updates and financial results for the fourth quarter year ended December 31, 2015. The call can be accessed by dialing (877) 341-5660 (U.S. and Canada) or (315) 625-3226 (international), and entering passcode 53106888. To access the liv

Mar 2 2016 - 1:36am
MILAN--(BUSINESS WIRE)--Newron Pharmaceuticals announces its financial results for the year-ended December 31, 2015, reiterates material events and presents the outlook for 2016.

Mar 2 2016 - 1:36am
LEXINGTON, Mass.--(BUSINESS WIRE)--Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the fourth quarter and year ended December 31, 2015 and provided an update on its product pipeline and corporate activities. “During the past year, there has been significant progress across our diversified portfolio of deuterium-modified drug candidates. Concert’s resources are focused on rapidly developing our proprietary pipeline, most notably CTP-656 as a once-daily potentiat

Mar 2 2016 - 1:36am
ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq:ACOR) announced that the Company will present at two investor conferences during March. Cowen 36th Annual Health Care Conference Ron Cohen, President and Chief Executive Officer, will conduct a fireside chat at the Cowen 36th Annual Health Care Conference in Boston on Tuesday, March 8 at 8:00am. A live audio webcast of the presentation can be accessed under “Investor Events” in the Investor section of the Acorda website or you ma

Mar 2 2016 - 1:36am
NEWTON, Mass.--(BUSINESS WIRE)--Allena Pharmaceuticals, a specialty biopharmaceutical company focused on developing and commercializing non-systemic protein therapeutics to treat metabolic and orphan diseases, announced today that Alexey Margolin, Ph.D., president and chief executive officer of Allena, will provide a corporate presentation at the 36th Annual Cowen and Company Health Care Conference at 10:00 a.m. ET, on Monday, March 7, 2016, in the MIT room at the Boston Marriott Copley Place H